Drug Candidate Against Alzheimer's Disease Goes on Human Trials
Filed in archive Drugs, Vaccines and Therapeutics on July 24, 2006
Australian researchers have developed a pill that,hopefully, might stop of delay the onset of Alzheimer's disease. The drug, called PBT2, demonstrated its efficacy in mice trials, and will be entering human trials in sweden in a couple of months.
The institute's tests also showed that PBT2 blocked the interaction between the amyloid protein and metals such as copper and zinc in the brain, stopping the development of Alzheimer's. Amyloid accumulates more rapidly in the presence of metals.
The researchers from the Mental Health Research Institute of Victoria, Australia are working in collaboration with Prana Biotechnology Limited, an Australian biotech firm developing therapies for age-related diseases.
Read the full story from Reuters.
Tags: alzheimer aging biotech drug disease alzheimer+disease human+trials drug+candidate
Vote for Drug Candidate Against Alzheimer's Disease Goes on Human Trials:
|
Rating: 8.00 out of 1 vote(s) cast.
|
Response from:
Traumatic Brain Injury
The commonly used anasthetic drug isoflurane can kill brain cells and heighten the risk of Alzheimer's, says a new study. Isoflurane is an inhaled anaesthetic, used when general anaesthesia is required. Many of those who use isoflurane, especially the ...
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells